Loading…
Loading grant details…
| Funder | Medical Research Council |
|---|---|
| Recipient Organization | University College London |
| Country | United Kingdom |
| Start Date | Jun 30, 2024 |
| End Date | Dec 31, 2028 |
| Duration | 1,645 days |
| Number of Grantees | 3 |
| Roles | Co-Investigator; Principal Investigator |
| Data Source | UKRI Gateway to Research |
| Grant ID | MR/Z503654/1 |
The context and challenge: Posttraumatic stress disorder (PTSD) is a prevalent, debilitating and persistent psychiatric condition that causes severe social and occupational impairment. The lifetime prevalence rate is 7-8%, although some occupational groups (e.g. first responders) and communities (e.g. asylum seekers) are especially vulnerable to stress-related disorders. Without effective treatment, PTSD follows a chronic course and contributes to numerous physical and psychiatric comorbidities.
Existing therapies for PTSD are resource-intensive yet ineffective in many patients. In well-controlled clinical trials,
Cardiff University; UCL Hospitals Nhs Foundation Trust; University College London
Complete our application form to express your interest and we'll guide you through the process.
Apply for This Grant